Clinical Trials

12 enrolled

Esophageal Squamous Cell Carcinoma

NCT07483359 2026-03-19

CONV3RSION

38 enrolled

Carcinoma, Hepatocellular

NCT06258525 2026-03-18

SAMe in Prevention of Oxaliplatin-associated Liver Injury

Classical hematologyGastrointestinal

Hepatic Veno-Occlusive Disease, Colorectal Neoplasms, Chemical and Drug Induced Liver Injury

NCT06735638 2026-03-18

Outside the Cage (OTC) Robotic Esophagectomy

31 enrolled

Esophageal Neoplasms, Ornithine Carbamoyltransferase Deficiency Disease

NCT07464236 2026-03-18

PEACHES 2

8 enrolled

Anus Neoplasms, Chlamydia Infections, Gonorrhea

NCT07470268 2026-03-18

HY-PANC

10 enrolled

Motor Activity, Pancreatic Neoplasms

NCT07472933 2026-03-18

Vebotolimab Combined With Ptorlimab for EGFR-positive Refractory Advanced Biliary Tract Malignancies

44 enrolled

Cancer of Biliary Duct

NCT07479472 2026-03-18

YOGICO

150 enrolled

Early-onset Gastrointestinal Cancer

NCT07481032 2026-03-18

Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study

1,034 enrolled

Carcinoma, Hepatocellular, Liver Cirrhosis, Hepatitis B, Chronic

NCT06893276 2026-03-17

e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients

60 enrolled

Pancreatic Neoplasms

NCT07476651 2026-03-17

LASER

Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT07477418 2026-03-17

PRISM-TAMP

10 enrolled

Pancreatic Neoplasms

NCT07477444 2026-03-17

HER-OIC

29 enrolled

Gastroesophageal Cancer

NCT07478185 2026-03-17

Prehab for Pancreatic Cancer Surgery

Pancreatic cancer, adult, Pancreatic Neoplasms

NCT07478523 2026-03-17

FAPDIG

120 enrolled

Cholangiocarcinoma

NCT07474025 2026-03-16

Integrating Peritoneal Histological Growth Patterns Into Preoperative Decision-Making for Colorectal Peritoneal Metastses

Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT07469956 2026-03-13

Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer

Pancreatic Neoplasms

NCT07296887 2026-03-12

CARE Tool Study Aim 3

GastrointestinalGenitourinaryThoracic

430 enrolled

Financial Stress, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT07411599 2026-03-12

Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")

28 enrolled

Colorectal Cancer, Hereditary Nonpolyposis, Type 6, Carcinoma, Colorectal Neoplasms

NCT07436988 2026-03-12

ReLIVE

18 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT07466225 2026-03-12

HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion

150 enrolled

Carcinoma, Hepatocellular

NCT07466238 2026-03-12

HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

40 enrolled

Phase 4 Not yet recruiting

Biliary Tract Neoplasms

NCT07467174 2026-03-12

REPROG-RCT

538 enrolled

Stomach Neoplasms

NCT07467434 2026-03-12

SYNCHRONOX

550 enrolled

Rectal Neoplasms

NCT07467590 2026-03-12

TRIUNITE-07

33 enrolled

Colorectal Neoplasms

NCT07381634 2026-03-11

The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities

134 enrolled

Carcinoma, Hepatocellular

NCT07463248 2026-03-11

PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy

64 enrolled

Carcinoma, Hepatocellular

NCT07463261 2026-03-11

RELOAD

442 enrolled

Rectal Neoplasms, Anastomotic Leak

NCT07463690 2026-03-11

Construction and Evaluation of a Flipped Discharge Model for Stomates With Colorectal Cancer

200 enrolled

Colorectal Neoplasms

NCT07464756 2026-03-11

SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

80 enrolled

Phase 3 Not yet recruiting

Gastric Adenocarcinoma

NCT07461675 2026-03-10

Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma Patients Undergoing Liver Resection

Carcinoma, Hepatocellular

NCT07459309 2026-03-09

Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies

Liver Neoplasms, Neoplasm Metastasis

NCT07436637 2026-03-06

Guardant Shield Colorectal Cancer Screening

500 enrolled

Colorectal Neoplasms

NCT07453875 2026-03-06

TRIUNITE06

9 enrolled

Colorectal Neoplasms

NCT07454486 2026-03-06

TRACE-BTC

300 enrolled

Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasms, Cholangiocarcinoma, Klatskin Tumor, Neoplasm, Residual

NCT07455422 2026-03-06

Endeavor-2

266 enrolled

Adenocarcinoma, Barrett Esophagus

NCT07455942 2026-03-06

FRACAS

300 enrolled

Squamous Cell Carcinoma of the Anal Canal

NCT05038098 2026-03-05

Magnetic Sentinel Lymph Node Mapping in Gastric Cancer

Gastric Adenocarcinoma

NCT07452471 2026-03-05

TAP-WELPASS

80 enrolled

Pain, Postoperative, Stomach Neoplasms

NCT07452601 2026-03-05

Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC

90 enrolled

Esophageal Squamous Cell Carcinoma

NCT07453173 2026-03-05

ONCO-RET

15 enrolled

Locally Advanced Rectal Cancer

NCT07448376 2026-03-04

EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases

Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence

NCT07445828 2026-03-03

Lynch syndrome

78 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Colorectal Neoplasms, Hereditary Nonpolyposis

NCT07446257 2026-03-03

THIO and Cadonilimab in Resectable Hepatocellular Carcinoma

60 enrolled

Carcinoma, Hepatocellular

NCT07446270 2026-03-03

Efficacy of Tunlametinib in Combination With Anti-EGFR Monoclonal Antibody in Patients With RAS-Mutated Advanced Gastrointestinal Malignancies

90 enrolled

Treatment for Advanced Colorectal Cancer

NCT07446387 2026-03-03

A Clinical Study of Iparomlimab and Tuvonralimab Combined With Bevacizumab and Alternating Triweekly CAPOX/mCAPIRI Regimen as First-line Treatment for Unresectable Advanced Colorectal Cancer

70 enrolled

Phase 4 Not yet recruiting

Colorectal Neoplasms

NCT07446465 2026-03-03

FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer

42 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT07277322 2026-03-02

Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases

24 enrolled

Colorectal Neoplasms

NCT07162337 2026-02-27

BILMOD